Header cover image

Automobiles Healthcare Sector

Results

2311

0 new

All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.

2,311 companies

Phreesia

Market Cap: US$1.5b

Provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada.

PHR

US$25.62

7D

-0.4%

1Y

19.9%

Andlauer Healthcare Group

Market Cap: CA$2.1b

A supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States.

AND

CA$53.50

7D

-0.02%

1Y

35.3%

Structure Therapeutics

Market Cap: US$1.5b

A clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States.

GPCR

US$25.57

7D

-5.6%

1Y

-28.6%

Ryman Healthcare

Market Cap: NZ$2.5b

Develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the elderly people in New Zealand and Australia.

RYM

NZ$2.42

7D

3.4%

1Y

-34.1%

Regis Healthcare

Market Cap: AU$2.2b

Engages in the provision of residential aged care services in Australia.

REG

AU$7.43

7D

1.9%

1Y

78.6%

Immunocore Holdings

Market Cap: US$1.4b

A commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases.

IMCR

US$28.40

7D

-6.8%

1Y

-51.8%

Mesoblast

Market Cap: AU$2.2b

Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.

MSB

AU$1.71

7D

-7.6%

1Y

60.1%

MannKind

Market Cap: US$1.4b

A biopharmaceutical company, focuses on the development and commercialization of therapeutic products and services for endocrine and orphan lung diseases in the United States.

MNKD

US$4.56

7D

-8.8%

1Y

5.6%

Vera Therapeutics

Market Cap: US$1.4b

A clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with serious immunological diseases.

VERA

US$21.71

7D

-14.2%

1Y

-47.5%

Indivior

Market Cap: UK£1.0b

Develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.

INDV

UK£8.28

7D

-6.8%

1Y

-42.2%

Adaptive Biotechnologies

Market Cap: US$1.4b

A commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.

ADPT

US$9.03

7D

-8.2%

1Y

158.0%

Astrana Health

Market Cap: US$1.4b

A healthcare management company, provides medical care services in the United States.

ASTH

US$29.71

7D

-8.6%

1Y

-23.6%

ANI Pharmaceuticals

Market Cap: US$1.3b

A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.

ANIP

US$66.30

7D

-9.1%

1Y

-2.6%

Sierra Oncology

Market Cap: US$1.3b

Sierra Oncology, Inc., a late-stage biopharmaceutical company, engages in researching, developing, and commercializing therapies for the treatment of patients with hematology and oncology needs.

SRRA

US$54.99

7D

0.06%

1Y

179.4%

ARS Pharmaceuticals

Market Cap: US$1.3b

A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.

SPRY

US$13.44

7D

-7.1%

1Y

53.8%

Green Thumb Industries

Market Cap: CA$1.8b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

GTII

CA$7.71

7D

-14.0%

1Y

-55.9%

Heska

Market Cap: US$1.3b

Heska Corporation manufactures and sells diagnostic and specialty products and solutions for veterinary practitioners in the United States, Canada, Mexico, Germany, Italy, Spain, France, Switzerland, Australia, and Malaysia.

HSKA

US$119.99

7D

0.1%

1Y

39.9%

Liquidia

Market Cap: US$1.3b

A biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States.

LQDA

US$15.26

7D

-3.6%

1Y

26.5%

Dyne Therapeutics

Market Cap: US$1.3b

A clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States.

DYN

US$11.41

7D

-3.8%

1Y

-56.1%

Neogen

Market Cap: US$1.3b

Engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide.

NEOG

US$5.97

7D

3.8%

1Y

-51.6%

dentalcorp Holdings

Market Cap: CA$1.7b

Through its subsidiaries, provides health care services by acquiring and partnering with dental practices in Canada.

DNTL

CA$8.81

7D

1.1%

1Y

45.4%

Teladoc Health

Market Cap: US$1.2b

Provides virtual healthcare services worldwide.

TDOC

US$7.11

7D

0.7%

1Y

-40.5%

GRAIL

Market Cap: US$1.2b

A commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally.

GRAL

US$35.20

7D

-1.6%

1Y

n/a

CVS Group

Market Cap: UK£932.6m

Engages in veterinary, pet crematoria, online pharmacy, and retail businesses.

CVSG

UK£13.00

7D

0.2%

1Y

32.2%

Artivion

Market Cap: US$1.2b

Manufactures, processes, and distributes medical devices and implantable human tissues worldwide.

AORT

US$28.91

7D

23.9%

1Y

22.9%

Azenta

Market Cap: US$1.2b

Provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.

AZTA

US$26.77

7D

-0.7%

1Y

-48.1%

Pediatrix Medical Group

Market Cap: US$1.2b

Provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States.

MD

US$14.53

7D

12.3%

1Y

76.8%

Celldex Therapeutics

Market Cap: US$1.2b

A biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases.

CLDX

US$18.33

7D

-11.3%

1Y

-54.1%

Omnicell

Market Cap: US$1.2b

Provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally.

OMCL

US$25.78

7D

-17.3%

1Y

-14.4%

agilon health

Market Cap: US$1.2b

Provides healthcare services for seniors through primary care physicians in the communities of the United States.

AGL

US$2.89

7D

-30.5%

1Y

-44.3%

Innoviva

Market Cap: US$1.2b

Engages in the development and commercialization of pharmaceutical products in the United States and internationally.

INVA

US$18.56

7D

-0.9%

1Y

19.0%

Kestra Medical Technologies

Market Cap: US$1.2b

Operates as a wearable medical device and digital healthcare company.

KMTS

US$22.68

7D

-4.5%

1Y

n/a

Pacira BioSciences

Market Cap: US$1.2b

Engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States.

PCRX

US$25.12

7D

-5.0%

1Y

-14.6%

Sienna Senior Living

Market Cap: CA$1.6b

Provides senior living services in Canada.

SIA

CA$17.59

7D

2.3%

1Y

16.2%

Pulse Biosciences

Market Cap: US$1.1b

Operates as a novel bioelectric medicine company.

PLSE

US$17.07

7D

-0.7%

1Y

129.1%

Amphastar Pharmaceuticals

Market Cap: US$1.1b

A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.

AMPH

US$24.11

7D

-1.6%

1Y

-42.9%

Page 8 of 65